151 related articles for article (PubMed ID: 18575950)
1. Tubulointerstitial nephritis and IgA nephropathy in a patient with advanced lung cancer treated with long-term gefitinib.
Masutani K; Fujisaki K; Maeda H; Toyonaga J; Inoshima I; Takayama K; Katafuchi R; Hirakata H; Tsuruya K; Iida M
Clin Exp Nephrol; 2008 Oct; 12(5):398-402. PubMed ID: 18575950
[TBL] [Abstract][Full Text] [Related]
2. Minimal change nephrotic syndrome associated with gefitinib and a successful switch to erlotinib.
Maruyama K; Chinda J; Kuroshima T; Kabara M; Nakagawa N; Fujino T; Yamamoto Y; Ohsaki Y; Ogawa Y; Hasebe N
Intern Med; 2015; 54(7):823-6. PubMed ID: 25832950
[TBL] [Abstract][Full Text] [Related]
3. Dabigatran-related Nephropathy Complicated by Tubulointerstitial Nephritis in a Patient with a Normal Renal Function and Undiagnosed IgA Nephropathy.
Iwafuchi Y; Ito Y; Imai N; Oyama Y; Narita I
Intern Med; 2024 Jun; 63(11):1615-1621. PubMed ID: 37866913
[TBL] [Abstract][Full Text] [Related]
4. Interstitial inflammatory and chronic tubulointerstitial lesions in lupus nephritis: comparison with those in IgA nephropathy.
Yamamoto T; Nagase M; Hishida A; Honda N
Lupus; 1993 Aug; 2(4):261-8. PubMed ID: 8268975
[TBL] [Abstract][Full Text] [Related]
5. Tubulointerstitial nephritis and uveitis syndrome complicated by IgA nephropathy and Graves' disease: a case report.
Shimamura Y; Tsushima T; Moniwa N; Hasegawa K; Ogawa Y; Takizawa H
J Med Case Rep; 2014 Sep; 8():305. PubMed ID: 25216854
[TBL] [Abstract][Full Text] [Related]
6. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
7. Histologically confirmed superimposition of post-streptococcal acute glomerulonephritis during IgA nephropathy.
Horita Y; Tadokoro M; Taura K; Suyama N; Taguchi T; Miyazaki M; Kohno S
Clin Exp Nephrol; 2004 Dec; 8(4):351-5. PubMed ID: 15619035
[TBL] [Abstract][Full Text] [Related]
8. The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy.
Bobart SA; Alexander MP; Shawwa K; Vaughan LE; Ghamrawi R; Sethi S; Cornell L; Glassock RJ; Fervenza FC; Zand L
Nephrol Dial Transplant; 2021 Apr; 36(5):840-847. PubMed ID: 31859353
[TBL] [Abstract][Full Text] [Related]
9. Cilostazol-induced acute tubulointerstitial nephritis accompanied by IgA nephropathy: a case report.
Shima H; Tashiro M; Yamada S; Matsuura M; Okada K; Doi T; Minakuchi J; Kawashima S
BMC Nephrol; 2018 Mar; 19(1):52. PubMed ID: 29506491
[TBL] [Abstract][Full Text] [Related]
10. Renal Effects after Pembrolizumab Treatment for Non-small Cell Lung Carcinoma.
Oki R; Hirakawa Y; Kimura H; Honda K; Hinata M; Abe H; Domoto Y; Tanaka G; Nagase T; Nangaku M
Intern Med; 2020 Apr; 59(7):977-981. PubMed ID: 31813918
[TBL] [Abstract][Full Text] [Related]
11. IgA nephropathy presenting clinicopathological features of acute post-streptococcal glomerulonephritis.
Okada K; Saitoh S; Sakaguchi Z; Zhang RJ; Kuhara T; Yasutomo K; Kuroda Y
Eur J Pediatr; 1996 Apr; 155(4):327-30. PubMed ID: 8777929
[TBL] [Abstract][Full Text] [Related]
12. Massive hematuria from the bilateral upper urinary tract in a patient treated for advanced lung cancer with gefitinib.
Mori H; Ohno Y; Ito F; Funaguchi N; Yanase K; Endo J; Nakano M; Bai La BL; Minatoguchi S
Jpn J Clin Oncol; 2010 Mar; 40(3):263-6. PubMed ID: 19897850
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer: a case report and review of the literature.
Yahata M; Nakaya I; Sakuma T; Sato H; Aoki S; Soma J
BMC Res Notes; 2013 Nov; 6():450. PubMed ID: 24207130
[TBL] [Abstract][Full Text] [Related]
14. Systemic tumor embolism mimicking gefitinib ('IRESSA')-induced interstitial lung disease in a patient with lung cancer.
Umemura S; Kishino D; Tabata M; Kiura K; Hotta K; Nishii K; Tanimoto Y; Kanehiro A; Notohara K; Ueoka H; Tanimoto M
Intern Med; 2005 Sep; 44(9):979-82. PubMed ID: 16258216
[TBL] [Abstract][Full Text] [Related]
15. Early detection of acute tubulointerstitial nephritis in the genesis of Mesoamerican nephropathy.
Fischer RSB; Vangala C; Truong L; Mandayam S; Chavarria D; Granera Llanes OM; Fonseca Laguna MU; Guerra Baez A; Garcia F; García-Trabanino R; Murray KO
Kidney Int; 2018 Mar; 93(3):681-690. PubMed ID: 29162294
[TBL] [Abstract][Full Text] [Related]
16. Benefit in lung function improvement and side-effect profile of long-term responders: an analysis of 14 NSCLC patients treated for at least 9 months with gefitinib.
Reck M; Gatzemeier U
Lung Cancer; 2005 Oct; 50(1):107-14. PubMed ID: 15985306
[TBL] [Abstract][Full Text] [Related]
17. [Case of rheumatoid arthritis with various histological lesions of the kidney].
Honma M; Toyoda M; Miyauchi M; Yamamoto N; Kimura M; Maruyama M; Nishina M; Yagame M; Endo M; Sakai H; Suzuki D
Nihon Jinzo Gakkai Shi; 2006; 48(2):67-73. PubMed ID: 16541759
[TBL] [Abstract][Full Text] [Related]
18. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma of the lung with rare insertion mutation in EGFR exon 19 that had partial response to gefitinib: a case report.
Kozlov V; Karpov I; Kovalenko S; Shamanin V
Exp Oncol; 2017 Jul; 39(2):155-156. PubMed ID: 29483495
[TBL] [Abstract][Full Text] [Related]
20. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
Xu K; Zhang L; Ding J; Wang S; Su B; Xiao H; Wang F; Zhong X; Li Y
J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
